Advisory Services Network’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
25,986
+3,342
+15% +$108K 0.01% 1013
2026
Q1
$737K Sell
22,644
-7,891
-26% -$254K 0.01% 1078
2025
Q4
$1.07M Sell
30,535
-5,657
-16% -$200K 0.02% 859
2025
Q3
$951K Buy
36,192
+17,158
+90% +$512K 0.01% 884
2025
Q2
$620K Sell
19,034
-56,224
-75% -$1.48M 0.01% 1062
2025
Q1
$1.82M Buy
75,258
+40,788
+118% +$1.29M 0.03% 528
2024
Q4
$1.39M Buy
34,470
+9,198
+36% +$524K 0.03% 613
2024
Q3
$1.34M Hold
25,272
0.03% 608
2024
Q2
$1.34M Buy
25,272
+12,343
+95% +$809K 0.03% 608
2024
Q1
$1.06M Buy
12,929
+8,978
+227% +$399K 0.02% 663
2023
Q4
$73.5K Buy
+3,951
New +$51.7K ﹤0.01% 1801
2023
Q2
Sell
-1,848
Closed -$30.8K 3592
2023
Q1
$30.8K Sell
1,848
-180
-9% -$1.86K ﹤0.01% 2281
2022
Q4
$19.1K Buy
+2,028
New +$9.05K ﹤0.01% 2507
2021
Q3
Sell
-500
Closed -$3K 3174
2021
Q2
$3K Buy
+500
New +$2.97K ﹤0.01% 3254
2021
Q1
Sell
-500
Closed -$3K 2896
2020
Q4
$3K Sell
500
-4
-0.8% -$24 ﹤0.01% 2936
2020
Q3
$3K Buy
+504
New +$3.47K ﹤0.01% 3011
2020
Q2
Sell
-500
Closed -$2K 2686
2020
Q1
$2K Hold
500
﹤0.01% 2790
2019
Q4
$4K Buy
+500
New +$3.65K ﹤0.01% 2702

Other funds holding VKTX

Advisory Services Network's VKTX Position: Q2 2026 in Review

Advisory Services Network increased its Viking Therapeutics (VKTX) stake by 15% in Q2 2026, buying an estimated $108K and bringing the position to 25,986 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #1013.

Advisory Services Network first reported a position in VKTX in Q4 2019 and has held it in 18 quarters since. The position peaked at $1.82M in Q1 2025. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Advisory Services Network held 25,986 shares of Viking Therapeutics worth $1.01M as of Q2 2026.
  • Advisory Services Network bought 3,342 Viking Therapeutics shares in Q2 2026, an estimated $108K.
  • Viking Therapeutics made up 0.01% of Advisory Services Network's portfolio in Q2 2026, its #1013 holding.
  • Advisory Services Network first reported a position in Viking Therapeutics in Q4 2019 and has held it in 18 quarters since.
  • Advisory Services Network's Viking Therapeutics position peaked at $1.82M in Q1 2025.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.